SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bjorn Nashan, Peter Schemmer, Felix Braun, Markus Dworak, Peter Wimmer, Hans Schlitt, Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial, Trials, 2015, 16, 1

    CrossRef

  2. 2
    Itxarone Bilbao, Magdalena Salcedo, Miguel Angel Gómez, Carlos Jimenez, Javier Castroagudín, Joan Fabregat, Carolina Almohalla, Ignacio Herrero, Valentín Cuervas-Mons, Alejandra Otero, Angel Rubín, Manuel Miras, Juan Rodrigo, Trinidad Serrano, Gonzalo Crespo, Manuel De la Mata, Javier Bustamante, M. Luisa Gonzalez-Dieguez, Antonia Moreno, Isidoro Narvaez, Magda Guilera, Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain, Liver Transplantation, 2015, 21, 8
  3. 3
    Lluís Castells, Carme Baliellas, Itxarone Bilbao, Carme Cantarell, Josep Maria Cruzado, Núria Esforzado, Juan Carlos García-Valdecasas, Laura Lladó, Antoni Rimola, Daniel Serón, Federico Oppenheimer, Detección precoz, prevención y manejo de la insuficiencia renal en el trasplante hepático, Gastroenterología y Hepatología, 2014, 37, 8, 480

    CrossRef

  4. 4
    James F. Trotter, Luis Lizardo-Sanchez, Everolimus in liver transplantation, Current Opinion in Organ Transplantation, 2014, 19, 6, 578

    CrossRef

  5. 5
    Jeng-Wei Chen, Cheng-Hsin Lin, Ron-Bin Hsu, Incidence, risk factor, and prognosis of end-stage renal disease after heart transplantation in Chinese recipients, Journal of the Formosan Medical Association, 2014, 113, 1, 11

    CrossRef

  6. 6
    Goran B. Klintmalm, Björn Nashan, The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence, Journal of Transplantation, 2014, 2014, 1

    CrossRef

  7. 7
    Susanne Beckebaum, Vito R. Cicinnati, Arnold Radtke, Iyad Kabar, Calcineurin inhibitors in liver transplantation – still champions or threatened by serious competitors?, Liver International, 2013, 33, 5
  8. 8
    C. Alegre, C. Jiménez, A. Manrique, M. Abradelo, J. Calvo, C. Loinaz, A. García-Sesma, F. Cambra, E. Álvaro, M. García, R. Sanabria, I. Justo, O. Caso, E. Moreno, Everolimus Monotherapy or Combined Therapy in Liver Transplantation: Indications and Results, Transplantation Proceedings, 2013, 45, 5, 1971

    CrossRef

  9. 9
    Cheryle Gurk-Turner, Wana Manitpisitkul, Matthew Cooper, A Comprehensive Review of Everolimus Clinical Reports, Transplantation Journal, 2012, 94, 7, 659

    CrossRef

  10. 10
    C. Clajus, N. Hanke, J. Gottlieb, M. Stadler, T. J. Weismüller, C. P. Strassburg, V. Bröcker, C. Bara, F. Lehner, J. Drube, J. T. Kielstein, A. Schwarz, F. Gueler, H. Haller, M. Schiffer, Renal Comorbidity After Solid Organ and Stem Cell Transplantation, American Journal of Transplantation, 2012, 12, 7
  11. 11
    James Trotter, Ben Kahn, Renal dysfunction and the liver transplant recipient; novel strategies for determination of reversibility and renal protective therapies pretransplant and posttransplant, Current Opinion in Organ Transplantation, 2012, 17, 3, 225

    CrossRef

  12. 12
    J. Marschalek, G.P. Györi, G.R. Silberhumer, G. Jomrich, I. Kristo, R. Steininger, F. Mühlbacher, G.A. Berlakovich, Simultaneous Pancreas-Kidney Transplantation Nine Years After Liver Transplantation—A Case Report, Transplantation Proceedings, 2012, 44, 10, 3041

    CrossRef

  13. 13
    Fuat H. Saner, Vito R. Cicinnati, Georgios Sotiropoulos, Susanne Beckebaum, Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation, Liver International, 2012, 32, 2
  14. 14
    J.F. Castroagudín, E. Molina, E. Varo, Calcineurin Inhibitors in Liver Transplantation: To Be or Not to Be, Transplantation Proceedings, 2011, 43, 6, 2220

    CrossRef

  15. 15
    T. Pérez, R. Segovia, L. Castro, J.P. Roblero, R. Estela, Conversion to Everolimus in Liver Transplant Patients With Renal Dysfunction, Transplantation Proceedings, 2011, 43, 6, 2307

    CrossRef

  16. 16
    Faouzi Saliba, Sébastien Dharancy, Richard Lorho, Filoména Conti, Sylvie Radenne, Martine Neau-Cransac, Monika Hurtova, Jean Hardwigsen, Yvon Calmus, Jérome Dumortier, Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis, Liver Transplantation, 2011, 17, 8
  17. 17
    T. Casanovas, A. Argudo, M.C. Peña-Cala, Everolimus in Clinical Practice in Long-Term Liver Transplantation: An Observational Study, Transplantation Proceedings, 2011, 43, 6, 2216

    CrossRef

  18. 18
    François Durand, Hot-topic debate on kidney function: Renal-sparing approaches are beneficial, Liver Transplantation, 2011, 17, S3
  19. 19
    C. Duvoux, G.P. Pageaux, Immunosuppression in liver transplant recipients with renal impairment, Journal of Hepatology, 2011, 54, 5, 1041

    CrossRef

  20. 20
    Christine Lau, Paul Martin, Suphamai Bunnapradist, Management of Renal Dysfunction in Patients Receiving a Liver Transplant, Clinics in Liver Disease, 2011, 15, 4, 807

    CrossRef

  21. 21
    Dirk Nielsen, Andrea Briem-Richter, Marijke Sornsakrin, Lutz Fischer, Bjoern Nashan, Rainer Ganschow, The use of everolimus in pediatric liver transplant recipients: First experience in a single center, Pediatric Transplantation, 2011, 15, 5
  22. 22
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2010, 19, 6
  23. 23
    Luis Landin, Pedro C. Cavadas, Jose C. Rodriguez-Perez, Miguel A. Garcia-Bello, Pedro Garcia-Cosmes, Alessandro Thione, Francisco Vera-Sempere, Luis Alfaro, Improvement in Renal Function After Late Conversion to Sirolimus-Based Immunosuppression in Composite Tissue Allotransplantation, Transplantation, 2010, 90, 6, 691

    CrossRef

  24. 24
    Kathleen M Campbell, John C Bucuvalas, Renal function in the long term after pediatric liver transplantation: is there a need for protocol kidney biopsies?, Current Opinion in Organ Transplantation, 2010, 15, 5, 608

    CrossRef

  25. 25
    E. Varo Pérez, J.F. Castroagudín, The Future of Liver Transplantation, Transplantation Proceedings, 2010, 42, 2, 613

    CrossRef

  26. 26
    Emiliano Calvo, Pablo Maroto, Xavier García del Muro, Miguel Ángel Climent, José Luis González-Larriba, Emilio Esteban, Rafael López, Luis Paz-Ares, Joaquim Bellmunt, Daniel Castellano, Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populations, Cancer and Metastasis Reviews, 2010, 29, S1, 11

    CrossRef